Pier Capital’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Pier Capital's GH Position: Q2 2026 in Review
Pier Capital reduced its Guardant Health (GH) stake by 0.84% in Q2 2026, selling an estimated $30.3K and leaving 33,051 shares worth $4.96M. The position accounts for 0.66% of the portfolio, ranked #74.
Pier Capital first reported a position in GH in Q4 2018 and has held it in 17 quarters since. The position peaked at $7.04M in Q4 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Pier Capital held 33,051 shares of Guardant Health worth $4.96M as of Q2 2026.
- Pier Capital sold 279 Guardant Health shares in Q2 2026, an estimated $30.3K.
- Guardant Health made up 0.66% of Pier Capital's portfolio in Q2 2026, its #74 holding.
- Pier Capital first reported a position in Guardant Health in Q4 2018 and has held it in 17 quarters since.
- Pier Capital's Guardant Health position peaked at $7.04M in Q4 2024.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.